Rheumatoid Arthritis

Top Story

Drug tapering: An option, not a necessity, for patients with RA in remission

Drug tapering: An option, not a necessity, for patients with RA in remission
June 26, 2017

In past decades, a diagnosis of rheumatoid arthritis often signified a long-term struggle to control the disease and improve quality of life. However, in more recent years, significant advances in treatment options have enabled an increasing number of patients to achieve remission.

This evolution in the state of rheumatoid arthritis (RA) treatment has led clinicians to consider issues of tapering in patients who are in remission and wish to reduce their medication burden.

Meeting News

TNF inhibitors, DMARDs yield similar malignancy risk in patients with RA

June 23, 2017
MADRID — No significant differences were reported in malignancy incidence among patients with rheumatoid arthritis treated with a cross section of tumor necrosis

EMA recommends approval of Humira biosimilar Imraldi

June 23, 2017
The European Medicines Agency has recommended the approval of the Imraldi, making it the third anti-TNF biosimilar candidate to receive a positive opinion from the…

A actinomycetemcomitans may be a trigger for autoimmune response, rheumatoid arthritis

June 20, 2017
Compared with healthy individuals, patients with rheumatoid arthritis appear to have a disproportionately high incidence of periodontal disease and infection. While the…
CME CNE CPE CE

The Management of Comorbid Conditions in Patients with Rheumatoid Arthritis

Supported by an educational grant from Pfizer Inc.

Strong evidence demonstrates that patients with rheumatoid arthritis (RA) are at a high risk for developing several…
More »
Video
Meeting News

VIDEO: Burmester reviews sarilumab trial

November 25, 2016
More »
Featured
EULAR Annual Congress

EULAR Annual Congress

Drug tapering: An option, not a necessity, for patients with RA in remission

June 26, 2017
In past decades, a diagnosis of rheumatoid arthritis often signified a long-term struggle to control the disease and improve quality of life…

Meeting News

TNF inhibitors, DMARDs yield similar malignancy risk in patients with RA

June 23, 2017
MADRID — No significant differences were reported in malignancy incidence among patients with rheumatoid arthritis treated with a cross section…

EMA recommends approval of Humira biosimilar Imraldi

June 23, 2017
The European Medicines Agency has recommended the approval of the Imraldi, making it the third anti-TNF biosimilar candidate to receive a positive…

A actinomycetemcomitans may be a trigger for autoimmune response, rheumatoid arthritis

June 20, 2017
Compared with healthy individuals, patients with rheumatoid arthritis appear to have a disproportionately high incidence of periodontal disease and…

In the JournalsPerspective

AAHKS, ACR release guidelines for management of antirheumatic drugs for patients who undergo TKA, THA

June 19, 2017
The American College of Rheumatology has partnered with the American Association of Hip and Knee Surgeons to develop evidence-based guidelines for…

Meeting News

Patients on infliximab seen as less likely to remain on treatment than etanercept

June 19, 2017
MADRID — Patients on infliximab as their first biologic were less likely to remain on treatment compared with patients on etanercept, according…

Meeting News

Health assessment, CRP found predictive of tapering in patients with RA in remission with TNFi

June 16, 2017
MADRID — Health assessment questionnaire score and C-reactive protein level predicted successful tapering of medication in patients with…

Meeting News

Multibiomarker disease test showed efficacy in prediction of RA joint damage

June 16, 2017
MADRID — A new multibiomarker disease test, in combination with clinical measures, may be effective in predicting joint damage in patients with…

Editorial

Should I Stay or Should I Go?

Healio Rheumatology, June 2017
Leonard H. Calabrese, DO
In reading two of the featured articles in this month’s issue of Healio Rheumatology, I was reminded of the 1982 song Should I Stay or Should I…

Cover Story

Experts Discuss the Quandary of Whether to Discontinue or Taper Treatment and When

Healio Rheumatology, June 2017
For the last few decades, clinicians have been trying to figure out how to decrease therapy in patients with rheumatoid arthritis who have reached…

More Headlines »
Advertisement
Advertisement